ArticleCureus2026
Early Cardiac Manifestations as the Initial Presentation of Duchenne Muscular Dystrophy in Infancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder most commonly diagnosed between four and five years of age, while diagnosis during infancy remains uncommon due to initially normal neurological examinations and delayed onset of motor weakness. Although dystrophin deficiency affects cardiac muscle from birth, clinically apparent cardiac involvement is generally considered a later manifestation, rendering echocardiographically evident structural cardiac abnormalities during infancy rare. We report a male infant with normal early motor development who initially presented at nine months of age with fever, dark urine, elevated transaminases, and markedly increased serum creatine kinase (CK) levels, which were initially attributed to hemolysis and presumed as viral myositis in the context of glucose-6-phosphate dehydrogenase deficiency. CK levels remained persistently elevated, prompting further evaluation. At 12 months of age, neurological examination was normal; however, cardiac assessment revealed mild left ventricular dilatation with preserved systolic function on echocardiography and electrocardiographic features consistent with left ventricular hypertrophy. Genetic testing subsequently confirmed an out-of-frame exon 44 deletion consistent with Duchenne muscular dystrophy. Motor stagnation became apparent by 15 months of age, while serial echocardiographic assessments demonstrated persistent but stable left ventricular dilatation. This case illustrates an early cardiac presentation of Duchenne muscular dystrophy in which structural cardiac abnormalities preceded overt neuromuscular manifestations. In infants presenting with persistent elevation of serum creatine kinase beyond the expected recovery period of intercurrent illness, further evaluation, including early cardiac assessment, may be clinically important, even when neurological examination and early motor development appear normal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.